Drugs / Carnitine
Carnitine
Trials 7 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02348125 | Mar 2016 → Jun 2017 | autism spectrum disorder, mitochondrial disease | Drexel University | Unknown | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01099072 | Apr 2010 → Dec 2012 | attention deficit-hyperactivity disorder | Tehran University of Medical Sciences | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT01904396 | Aug 2013 → Aug 2016 | disorder of carnitine cycle and carnitine transport | University Health Network, Toronto | Unknown | No outcome recorded |
| Phase not applicable4 trials | ||||||
| — | NCT07538999 | Apr 2026 → Dec 2027 expected | — | Children's Hospital of Fudan University | Recruiting | No outcome recorded |
| — | NCT02312414 | Oct 2014 → Mar 2015 | anemia | The Nazareth Hospital, Israel | Unknown | No outcome recorded |
| — | NCT01564303 | May → Nov 2012 | — | The Nazareth Hospital | Unknown | No outcome recorded |
| — | NCT01566006 | Apr 2012 → Jun 2013 | diabetic kidney disease | The Nazareth Hospital, Israel | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT01731236 Comparator | Feb 2011 → Dec 2027 expected | — | The Cleveland Clinic | Active not recruiting | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Carnitine | “Carnitine is a quaternary ammonium compound biosynthesized from the amino acids lysine and methionine, it is essential for the transport of fatty acids from the...” NCT02312414 ↗7“routine parenteral carnitine supplementation” NCT07538999 ↗ “* carnitine, 50 mg/kg subject weight/day” NCT02348125 ↗ |
| Known as | Carnitina | ChEMBL registry synonym — accepted as the source's own label CHEMBL172513 ↗ |
| Known as | Carnitine, dl- | ChEMBL registry synonym — accepted as the source's own label CHEMBL172513 ↗ |
| Modality | Small molecule | “Carnitine is a quaternary ammonium compound” NCT02312414 ↗ |
| Route | Oral | “L-Carnitine 500 mg capsule by mouth, twice daily for 2 months.” NCT01731236 ↗ |